About Kathy Giusti
Kathy Giusti, a multiple myeloma patient, is the Founder of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC). She is the Henry & Allison McCance Family Senior Fellow at Harvard Business School, where she serves as Faculty Co-Chair of HBS Kraft Precision Medicine Accelerator, a $20M program endowed by Robert Kraft and the Kraft Family Foundation. She currently serves on the MMRF Board of Directors. Giusti has more than two decades of experience in the pharmaceutical industry, previously holding senior positions at G.D. Searle and Merck.
Since founding the MMRF in 1998, Giusti has become a widely respected leader in establishing innovative, collaborative research models in the areas of tissue banking, genomics, and clinical trials. These models are dramatically accelerating the pace at which lifesaving treatments are brought to patients and are building an end-to-end solution in precision medicine. Today, Giusti is recognized as a pioneer of precision medicine, a champion of open-access data sharing, and a strong advocate for patient engagement.
In 2016, Giusti was named Faculty Co-Chair of the Harvard Business School (HBS) Kraft Precision Medicine Accelerator. Under Giusti’s leadership, the HBS Kraft Precision Medicine Accelerator convenes best-in-class leaders from science, business and technology to identify and solve challenges slowing the advancement of precision medicine. The HBS Kraft PM Accelerator disseminates best practices and models to overcome these challenges, and, ultimately, enables faster adoption of high-impact innovations.
Giusti’s has earned several prestigious awards and recognitions, including being named 1 of 3 Top Business Leaders Disrupting Medicine by Fortune Magazine and #19 on Fortune’s World’s 50 Greatest Leaders list. Giusti was also named one of the world’s 100 Most Influential People by TIME magazine. She has received the Open Science Champion of Change award by the White House and has been honored with the American Association for Cancer Research Centennial Medal for Distinguished Public Service and the Healthcare Businesswomen’s Association’s Woman of the Year Award.
Giusti served on President Obama’s 2015 Precision Medicine Initiative Working Group and continues to act as an active advisor to the Obama PMI (“All of Us”) and Vice President Biden’s Cancer Moonshot program. She currently is a member of the Harvard Business School (HBS) Health Advisory Board and has previously served on the President’s Council of Advisors on Science and Technology (PCAST), National Cancer Advisory Board (NCAB), and the National Cancer Policy Board (NCBP).
Giusti has been featured on the Today Show, NBC Nightly News, CBS Evening News, Fox News, CNN, and Bloomberg. Her efforts have also been profiled by Fortune, The Wall Street Journal, Harvard Business Review, The New York Times, Forbes, The New Yorker, WIRED, and Fast Company.
Giusti received her MBA in general management from Harvard Business School. She holds an honorary Doctorate from the University of Vermont.
Learn more about Kathy:
Kathy’s work has garnered a number of prestigious awards including:
- Top 3 Business Disrupters in Healthcare
- #19 on Fortune Magazine’s Worlds’ 50 Greatest Leaders
- TIME 100 List of the world’s most influential people
- PharmaVOICE Red Jacket Award
- Personalized Medicine Coalition Leadership Award (PMC Award)
- Open Science Champion of Change by the White House
- The American Association for Cancer Research (AACR) Centennial Medal for Distinguished Public Service
- Harvard Business School Alumni Achievement Award
- Healthcare Businesswomen’s Association’s Woman of the Year Award
Read about Kathy Giusti’s transformative approach to cancer research:
“What Shopping Has Taught Me About How We Treat Cancer” by Kathy Giusti
The Huffington Post, November 2016
“Kathy Giusti: Sharing Life Lessons From a Death Sentence” – Adam Bryant, Corner Office
New York Times, October 2016
“A woman who was given 3 years to live in 1996 explains how her ‘death sentence’ made her one of the world’s best leaders”
Business Insider, October 2016
“Precision Medicine for All” by Kathy Giusti
MMRF, February 2016
“Kathy Giusti: The businesswoman who took on her own cancer”
STAT, February 2016
Fortune Profiles MMRF Founder Kathy Giusti as Cancer Warrior
Fortune, August 2014
Kathy Giusti Named to PharmaVOICE 100 List
PharmaVOICE, August 2014
Kathy Giusti #19 on List of “The World’s 50 Greatest Leaders”
Fortune, March 2014
MMRF Featured in Fast Company as “Savvy Renegade…Saving Lives”
Fast Company, April 2013
Kathy Giusti Named to the 2011 TIME 100
Time Magazine April 2011
Watch Kathy Giusti speak about the innovative model of the MMRF:
Kathy Giusti Interviewed on Wall Street Journal Live
WSJ Live, July 2014
CNN International’s Quest Means Business Interview with Kathy Giusti
WSJ Live, April 2014
A Mission With Precision: Kathy Giusti’s Ambitious Quest To Cure Multiple Myeloma
Forbes, December 2013
How Sharing of Data Can Improve Cancer Research
MSNBC, September 2013
MMRF Founder and CEO on Huffington Post Live
Huffington Post Live, June 2013
Healthcare Entrepreneur Kathy Giusti Addresses MBA Class of 2011
Harvard Business School Class Day, May 2011
Read articles authored by Kathy Giusti:
Cancer Research: Not a One-Size-Fits-All Approach
WIRED, August 2014
The Multiple Myeloma Research Foundation’s evolving focus on drug R&D
Nature Biotechnology, July 2012